OncoMed Pharmaceuticals, Inc. Debt to Equity Ratio 2013-2018 | OMED
Current and historical debt to equity ratio values for OncoMed Pharmaceuticals, Inc. (OMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. OncoMed Pharmaceuticals, Inc. debt/equity for the three months ending December 31, 2018 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-12-31 | $0.02B | $0.05B | 0.35 |
| 2018-09-30 | $0.03B | $0.05B | 0.49 |
| 2018-06-30 | $0.04B | $0.04B | 0.95 |
| 2018-03-31 | $0.05B | $0.05B | 1.05 |
| 2017-12-31 | $0.16B | $-0.05B | -3.27 |
| 2017-09-30 | $0.18B | $-0.06B | -2.94 |
| 2017-06-30 | $0.19B | $-0.05B | -3.59 |
| 2017-03-31 | $0.21B | $-0.04B | -5.10 |
| 2016-12-31 | $0.22B | $-0.02B | -9.49 |
| 2016-09-30 | $0.22B | $-0.00B | -69.59 |
| 2016-06-30 | $0.23B | $-0.04B | -5.18 |
| 2016-03-31 | $0.23B | $-0.02B | -11.34 |
| 2015-12-31 | $0.23B | $0.00B | 65.99 |
| 2015-09-30 | $0.16B | $0.03B | 6.42 |
| 2015-06-30 | $0.16B | $0.05B | 3.52 |
| 2015-03-31 | $0.16B | $0.07B | 2.51 |
| 2014-12-31 | $0.17B | $0.08B | 2.25 |
| 2014-09-30 | $0.18B | $0.09B | 2.01 |
| 2014-06-30 | $0.19B | $0.09B | 2.08 |
| 2014-03-31 | $0.20B | $0.11B | 1.85 |
| 2013-12-31 | $0.22B | $0.12B | 1.83 |
| 2013-09-30 | $0.04B | $0.10B | 0.44 |
| 2013-06-30 | $0.05B | $0.02B | 2.18 |
| 2013-03-31 | $0.00B | 0.00 | |
| 2012-09-30 | $0.00B | 0.00 | |
| 2012-06-30 | $0.00B | 0.00 | |
